Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma.

Saved in:
Bibliographic Details
Title: Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma.
Authors: Ye L; National Centre for Asbestos Related Diseases, Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia., Ryu H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Centre, Seattle, WA, USA.; School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea., Granadier D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Centre, Seattle, WA, USA.; School of Medicine, University of Washington, Seattle, WA, USA., Nguyen LT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Centre, Seattle, WA, USA., Simoni Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Centre, Seattle, WA, USA., Dick I; School of Biomedical Science, University of Western Australia, Nedlands, WA, Australia., Firth T; National Centre for Asbestos Related Diseases, Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia., Rouse E; National Centre for Asbestos Related Diseases, Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia., Chiang P; National Centre for Asbestos Related Diseases, Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia., Lee YCG; School of Biomedical Science, University of Western Australia, Nedlands, WA, Australia.; Institute for Respiratory Health, University of Western Australia, Nedlands, WA, Australia., Robinson BW; National Centre for Asbestos Related Diseases, Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia.; School of Biomedical Science, University of Western Australia, Nedlands, WA, Australia.; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia., Creaney J; National Centre for Asbestos Related Diseases, Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia.; Institute for Respiratory Health, University of Western Australia, Nedlands, WA, Australia.; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia., Newell EW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Centre, Seattle, WA, USA., Redwood AJ; National Centre for Asbestos Related Diseases, Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia.; School of Biomedical Science, University of Western Australia, Nedlands, WA, Australia.; Institute for Respiratory Health, University of Western Australia, Nedlands, WA, Australia.
Source: Translational lung cancer research [Transl Lung Cancer Res] 2024 Sep 30; Vol. 13 (9), pp. 2352-2372. Date of Electronic Publication: 2024 Sep 27.
Publication Type: Journal Article
Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first